Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Almost been a month since 🐀 🐀 were injected !!!

<< Previous

Bullboard Posts

Next >>

Comment by Nighttradeon Aug 13, 2020 6:08pm

78 Views

Post# 31405774

RE:RE:RE:RE:RE:RE:RE:RE:Almost been a month since 🐀 🐀 were injected !!!

Real share holder? You just admitted you should have sold. A real share holder is one that holds shares nothing more. I'll warn people so long as Vaxil's behaves in this manner. It does not look good. If it offends you don't read it, but as a investor I will say what I want.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season